• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Role of apoptosis resistance in immune evasion and metastasis of colorectal cancer.结直肠癌免疫逃逸和转移中凋亡抵抗的作用。
World J Gastrointest Oncol. 2010 Nov 15;2(11):399-406. doi: 10.4251/wjgo.v2.i11.399.
2
CTL adoptive immunotherapy concurrently mediates tumor regression and tumor escape.细胞毒性T淋巴细胞过继性免疫疗法同时介导肿瘤消退和肿瘤逃逸。
J Immunol. 2006 Mar 15;176(6):3374-82. doi: 10.4049/jimmunol.176.6.3374.
3
H3K9 Trimethylation Silences Fas Expression To Confer Colon Carcinoma Immune Escape and 5-Fluorouracil Chemoresistance.H3K9三甲基化使Fas表达沉默,从而导致结肠癌免疫逃逸和5-氟尿嘧啶化疗耐药。
J Immunol. 2015 Aug 15;195(4):1868-82. doi: 10.4049/jimmunol.1402243. Epub 2015 Jul 1.
4
Loss of Fas expression and high expression of HLA-E promoting the immune escape of early colorectal cancer cells.Fas表达缺失和HLA-E高表达促进早期大肠癌细胞的免疫逃逸。
Oncol Lett. 2017 May;13(5):3379-3386. doi: 10.3892/ol.2017.5891. Epub 2017 Mar 22.
5
Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy.Fas 表达和功能的丧失与结肠癌对免疫检查点抑制剂免疫治疗的耐药性相关。
Mol Cancer Res. 2019 Feb;17(2):420-430. doi: 10.1158/1541-7786.MCR-18-0455. Epub 2018 Nov 14.
6
Restoring FAS Expression via Lipid-Encapsulated FAS DNA Nanoparticle Delivery Is Sufficient to Suppress Colon Tumor Growth In Vivo.通过脂质包裹的FAS DNA纳米颗粒递送恢复FAS表达足以在体内抑制结肠肿瘤生长。
Cancers (Basel). 2022 Jan 12;14(2):361. doi: 10.3390/cancers14020361.
7
Relationship between Fas-ligand expression on carcinoma cell and cytotoxic T-lymphocyte response in lymphoepithelioma-like cancer of the stomach.胃淋巴上皮瘤样癌中癌细胞上Fas配体表达与细胞毒性T淋巴细胞反应的关系
Int J Cancer. 1999 Aug 20;84(4):339-43. doi: 10.1002/(sici)1097-0215(19990820)84:4<339::aid-ijc1>3.0.co;2-2.
8
Positive and negative consequences of soluble Fas ligand produced by an antigen-specific CD4(+) T cell response in human carcinoma immune interactions.抗原特异性CD4(+) T细胞应答产生的可溶性Fas配体在人类癌免疫相互作用中的正负效应
Cell Immunol. 2001 Apr 10;209(1):49-62. doi: 10.1006/cimm.2001.1781.
9
p50 suppresses cytotoxic T lymphocyte effector function to regulate tumor immune escape and response to immunotherapy.p50 抑制细胞毒性 T 淋巴细胞效应功能以调节肿瘤免疫逃逸和对免疫治疗的反应。
J Immunother Cancer. 2020 Oct;8(2). doi: 10.1136/jitc-2020-001365.
10
Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma.基质金属蛋白酶-7增加对Fas介导的细胞凋亡的抗性,是结直肠癌患者的不良预后因素。
Carcinogenesis. 2006 May;27(5):1113-20. doi: 10.1093/carcin/bgi351. Epub 2006 Feb 10.

引用本文的文献

1
Pan-cancer analysis of NUDT21 and its effect on the proliferation of human head and neck squamous cell carcinoma.泛癌症分析 NUDT21 及其对人类头颈部鳞状细胞癌增殖的影响。
Aging (Albany NY). 2024 Feb 12;16(4):3363-3385. doi: 10.18632/aging.205539.
2
Decoding Strategies to Evade Immunoregulators Galectin-1, -3, and -9 and Their Ligands as Novel Therapeutics in Cancer Immunotherapy.解码策略以规避免疫调节剂半乳糖凝集素-1、-3 和-9 及其配体,作为癌症免疫治疗的新疗法。
Int J Mol Sci. 2022 Dec 8;23(24):15554. doi: 10.3390/ijms232415554.
3
MicroRNA-Assisted Hormone Cell Signaling in Colorectal Cancer Resistance.微小 RNA 辅助激素细胞信号在结直肠癌耐药中的作用。
Cells. 2020 Dec 30;10(1):39. doi: 10.3390/cells10010039.
4
In silico analysis of the prognostic value of FAS mRNA in malignancies.FAS mRNA在恶性肿瘤中预后价值的计算机分析
J Cancer. 2020 Jan 1;11(3):542-550. doi: 10.7150/jca.35614. eCollection 2020.
5
Recombinant Adenovirus Expressing a Soluble Fusion Protein PD-1/CD137L Subverts the Suppression of CD8 T Cells in HCC.表达可溶性融合蛋白 PD-1/CD137L 的重组腺病毒在 HCC 中颠覆了 CD8 T 细胞的抑制作用。
Mol Ther. 2019 Nov 6;27(11):1906-1918. doi: 10.1016/j.ymthe.2019.07.019. Epub 2019 Aug 5.
6
Tumor necrosis factor-related apoptosis-inducing ligand inhibits the growth and aggressiveness of colon carcinoma via the exogenous apoptosis signaling pathway.肿瘤坏死因子相关凋亡诱导配体通过外源性凋亡信号通路抑制结肠癌的生长和侵袭性。
Exp Ther Med. 2019 Jan;17(1):41-50. doi: 10.3892/etm.2018.6901. Epub 2018 Oct 30.
7
Discussion of some 'knowns' and some 'unknowns' about the tumour suppressor p53.讨论肿瘤抑制因子 p53 的一些“已知”和一些“未知”。
J Mol Cell Biol. 2019 Mar 1;11(3):212-223. doi: 10.1093/jmcb/mjy077.
8
CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis.促肾上腺皮质激素释放激素受体2/促肾上腺皮质激素释放因子2信号通路是miR-7/YY1/Fas信号通路的新型调节因子,有助于逆转大肠癌细胞对Fas介导的细胞凋亡的抗性。
Int J Cancer. 2018 Jan 15;142(2):334-346. doi: 10.1002/ijc.31064. Epub 2017 Oct 12.
9
Loss of Fas expression and high expression of HLA-E promoting the immune escape of early colorectal cancer cells.Fas表达缺失和HLA-E高表达促进早期大肠癌细胞的免疫逃逸。
Oncol Lett. 2017 May;13(5):3379-3386. doi: 10.3892/ol.2017.5891. Epub 2017 Mar 22.
10
Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer.基质溶素的腹膜表达有助于识别结直肠癌术后早期复发。
Oncotarget. 2015 May 30;6(15):13402-15. doi: 10.18632/oncotarget.2830.

本文引用的文献

1
T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells.针对 EGFR 的 T 细胞结合双特异性抗体可有效消除 KRAS 和 BRAF 突变的结直肠癌细胞。
Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12605-10. doi: 10.1073/pnas.1000976107. Epub 2010 Jun 28.
2
Intratumoral T cell infiltration, MHC class I and STAT1 as biomarkers of good prognosis in colorectal cancer.肿瘤内 T 细胞浸润、MHC 类 I 分子和 STAT1 可作为结直肠癌预后良好的生物标志物。
Gut. 2010 Jul;59(7):926-33. doi: 10.1136/gut.2009.194472.
3
CD95 promotes tumour growth.CD95 促进肿瘤生长。
Nature. 2010 May 27;465(7297):492-6. doi: 10.1038/nature09075.
4
Targeted immunotherapy for colorectal cancer: monoclonal antibodies and immunotoxins.结直肠癌的靶向免疫治疗:单克隆抗体和免疫毒素。
Expert Opin Investig Drugs. 2010 Apr;19 Suppl 1:S67-77. doi: 10.1517/13543781003737668.
5
Pilot study of sentinel-node-based adoptive immunotherapy in advanced colorectal cancer.基于前哨淋巴结的 adoptive immunotherapy 在晚期结直肠癌中的初步研究。
Ann Surg Oncol. 2010 Jul;17(7):1747-57. doi: 10.1245/s10434-010-0920-8. Epub 2010 Jan 30.
6
Silencing Fas-associated phosphatase 1 expression enhances efficiency of chemotherapy for colon carcinoma with oxaliplatin.沉默 Fas 相关磷酸酶 1 的表达增强奥沙利铂治疗结肠癌的化疗效果。
World J Gastroenterol. 2010 Jan 7;16(1):112-8. doi: 10.3748/wjg.v16.i1.112.
7
Membrane-bound Fas ligand only is essential for Fas-induced apoptosis.仅膜结合型Fas配体对于Fas诱导的细胞凋亡至关重要。
Nature. 2009 Oct 1;461(7264):659-63. doi: 10.1038/nature08402.
8
A multi-functional role of interferon regulatory factor-8 in solid tumor and myeloid cell biology.干扰素调节因子-8 在实体瘤和髓系细胞生物学中的多功能作用。
Immunol Res. 2010 Mar;46(1-3):59-71. doi: 10.1007/s12026-009-8125-6.
9
XIAP discriminates between type I and type II FAS-induced apoptosis.X连锁凋亡抑制蛋白可区分I型和II型FAS诱导的细胞凋亡。
Nature. 2009 Aug 20;460(7258):1035-9. doi: 10.1038/nature08229. Epub 2009 Jul 22.
10
Human and mouse colon cancer utilizes CD95 signaling for local growth and metastatic spread to liver.人类和小鼠结肠癌利用CD95信号通路进行局部生长以及向肝脏的转移扩散。
Gastroenterology. 2009 Sep;137(3):934-44, 944.e1-4. doi: 10.1053/j.gastro.2009.06.004. Epub 2009 Jun 12.

结直肠癌免疫逃逸和转移中凋亡抵抗的作用。

Role of apoptosis resistance in immune evasion and metastasis of colorectal cancer.

机构信息

Kebin Liu, Department of Biochemistry and Molecular Biology, Medical College of Georgia, Georgia Health Sciences University, Augusta, GA 30912, United States.

出版信息

World J Gastrointest Oncol. 2010 Nov 15;2(11):399-406. doi: 10.4251/wjgo.v2.i11.399.

DOI:10.4251/wjgo.v2.i11.399
PMID:21160903
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3000453/
Abstract

The host immune system functions as a guardian against tumor development. It has been demonstrated that cytotoxic T lymphocyte (CTL)-mediated cytotoxic pathways function to inhibit or delay human colorectal cancer development. However, the host anti-tumor immune responses also 'edit' the tumor and select for more aggressive variants, resulting in immune evasion and tumor escape. Fas is a death receptor that mediates one of the major cytotoxic effector mechanisms of the CTLs. Fas is highly expressed in normal human colon epithelial cells but is frequently silenced in colorectal carcinoma, especially in metastatic colorectal carcinoma, suggesting that loss of Fas expression and function may be an immune evasion and tumor escape mechanism. In addition, recent studies indicated that Fas also mediates cellular proliferation signaling pathways to promote tumor development. Therefore, the death receptor Fas may not only transduce death signals to suppress tumor development but also activate cellular proliferation and the migration process to promote tumor growth and progression. Thus, understanding the mechanisms by which the Fas receptor and its associated protein complex transduces the death and survival signals may identify molecular targets for the development of therapeutic strategy to enhance the Fas-mediated death signals to increase the efficacy of cancer immunotherapy.

摘要

宿主免疫系统作为对抗肿瘤发生的守护者。已证实细胞毒性 T 淋巴细胞(CTL)介导的细胞毒性途径可抑制或延迟人结直肠癌的发展。然而,宿主抗肿瘤免疫反应也“编辑”肿瘤并选择更具侵袭性的变体,导致免疫逃逸和肿瘤逃逸。Fas 是一种死亡受体,介导 CTL 的主要细胞毒性效应机制之一。Fas 在正常的人结肠上皮细胞中高度表达,但在结直肠癌中经常失活,特别是在转移性结直肠癌中,表明 Fas 表达和功能的丧失可能是一种免疫逃逸和肿瘤逃逸机制。此外,最近的研究表明,Fas 还介导细胞增殖信号通路以促进肿瘤的发展。因此,死亡受体 Fas 不仅可以传递死亡信号来抑制肿瘤的发展,还可以激活细胞增殖和迁移过程,促进肿瘤的生长和进展。因此,了解 Fas 受体及其相关蛋白复合物传递死亡和存活信号的机制可能为开发治疗策略以增强 Fas 介导的死亡信号,从而提高癌症免疫治疗的疗效提供分子靶标。